Novo Nordisk’s strategy to grow beyond metabolic diseases includes expanding into adjacent areas such as cardiovascular disease. Acquiring Cardio Pharmaceuticals adds a novel RNA-based therapy that is a potential heart failure treatment.
Many women going through menopause suffer brain fog, but some may be worried about a more serious cognitive condition like dementia. Because of this, Midi Health and Neurotrack partnered to offer a cognitive assessment to patients.
AbbVie is acquiring Landos Biopharma, whose lead drug is a small molecule that takes a novel approach to treating ulcerative colitis. Preliminary proof-of-concept data from a Phase 2 study are expected later this year.
The “holy grail” of ATMP-based treatments is to provide cures for some of the world’s most debilitating disease states, but for this to occur, a unified front is needed to democratize these therapies – collaboration from industry, academia, supply chain and, indeed, clinicians and hospitals is paramount to ensuring safe manufacturing and transit.
A new report from the Peterson Health Technology Institute analyzed eight digital diabetes management tools. It found that the tools don't provide meaningful clinical benefits and increase healthcare spending.